Latest Sustainability In It News

Zeotech Limited’s AusPozz™ has been independently validated by BG&E as a high-performance, low-carbon supplementary cementitious material, showing remarkable strength gains and durability benefits in concrete applications.

Atturra Limited reported a robust 24% increase in both revenue and underlying EBITDA for FY25, propelled by its cloud platform, AI innovations, and defence sector contracts. The company forecasts continued momentum into FY26 with ambitious growth targets.

Solvar Limited has sold its New Zealand arrears loan book for NZ$8 million, accelerating its exit from the NZ market and announcing a special fully franked dividend for shareholders.

Nido Education Limited is set to acquire two high-occupancy incubator services for around $7 million, supported by a substantial $30 million extension to its acquisition facility, signaling robust growth ambitions.

Iondrive Limited has successfully raised $4 million through a share placement to accelerate the commercialisation of its innovative e-waste recycling technology in the United States.

IPD Group’s 2025 AGM reveals robust FY25 financial results driven by data centre and electrification sectors, alongside operational efficiencies and sustainability strides. The company signals continued momentum into FY26 with positive earnings guidance.

Whitefield Income Ltd reports robust first-quarter earnings and announces a $53 million capital raising via placement and a Share Purchase Plan, maintaining its focus on delivering steady, franked dividends.

Australian Foundation Investment Company plans special fully franked dividends alongside its 2026 interim and final payouts, leveraging a strong franking credit balance.

Acrux Ltd reported a remarkable surge in licensing revenue from its topical generics portfolio alongside a strategic pivot towards innovative drug delivery R&D at its 2025 Annual General Meeting.

Aroa Biosurgery has reported a strong first half for FY26, with 14% revenue growth driven by its Myriad product line and a return to positive EBITDA. The company also secured relief from ASX quarterly reporting requirements, signaling improved financial stability.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

Osteopore Limited has partnered with DKSH Malaysia in a five-year agreement to distribute its innovative dental products, aiming to capture significant growth in Malaysia’s guided bone regeneration sector.